Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Complete Response As a Determinant of Survival in Plasmablastic Lymphoma Plasmablat- GELL001 Study

Humberto Martinez-Cordero, Maria Cynthia Fuentes Lacouture, Paola Spirko, Juan Alejandro Ospina-Idárraga, Jaime Valdes Cespedes, Karen Pellon, Laura Korin, Perla R. Colunga-Pedraza, Henry Idrobo, Andrea Noboa, Luis Mario Villela, Arianna Robles, Alana Von Glasenapp, Perla N Britos, Yusaima Rodriguez, Rosa Oliday Rios Jiménez, Camila Peña, Luis Felipe Rubalcava, Jorge J. Castillo

Blood (2023) 142 (Supplement 1): 6326.

https://doi.org/10.1182/blood-2023-190960

Published: 2023

Journal Articles

Primary CNS Lymphoma in Latin America: A Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) Survey in 80 Cancer Centers in Latin America

Blood (2023) 142 (Supplement 1): 2422.

https://doi.org/10.1182/blood-2023-190477

Published: 2023

Journal Articles

Survival of Patients with Multiple Myeloma Treated with Bortezomib-Based Triplets and Autologous Hematopoietic Stem Cell Transplant As First Line in Latin America

Blood (2023) 142 (Supplement 1): 3352.

https://doi.org/10.1182/blood-2023-185240

Published: 2023

Journal Articles

Renal Failure in Patients with Newly Diagnosed Multiple Myeloma Eligible for Autologous Stem Cell Transplant in LATAM - on Behalf of Gelamm

Humberto Martinez-Cordero, Maria Cynthia Fuentes Lacouture, Seisha Alana Von Glasenapp, Camila Peña, Eloisa Riva

Blood (2023) 142 (Supplement 1): 3346.

https://doi.org/10.1182/blood-2023-190668

Published: 2023

Journal Articles

Epidemiology, Clinical Features and Outcomes of Peripheral T-Cell Lymphoma in Latin America

Thais Fischer, Henry Idrobo, Astrid Pavlovsky, Denisse Castro, Brady Beltran, Daniel J Enriquez, Jule F Vasquez, Claudia Roche, Daniel Artiles, Fabiola Valvert, Luis Mario Villela, Juliana Pereira, Carolina Oliver, Jamila Vaz Tavarez, Sergio Augusto B Brasil, Karin Z Cecyn, Nelson Castro, Renata Baptista, Samuel de S Medina, Davimar Miranda Maciel Borducchi, Marcelo Bellesso, Danielle Leao Cordeiro De Farias, Yung Bruno Gonzaga, Fernando Warley, Lorena Fiad, Laura Korin, Patricio Hernan Pereyra, Camila Peña, Maria Alejandra Torres, Carolina Valeria Mahuad, Alana Von Glasenapp, Alfredo Reinaldo Quiroz, Raimundo Gazitua, Cesar Augusto Samanez-Figari, Lautaro Sardu, Juan Pablo Arriola, Sebastian Isnardi, Juan L. Maradei, Raul Hector Gabus, Alicia I. Enrico, Luciana A Guanchiale, Florencia Negri Arangueren, Juan Ignacio García Altuve, Amalia Cerutti, Romina Penalva, Jose Ignacio Garcia Trucco, Florencia Pessolani, Virginia Gilli, Joaquin Diaz, Maria Enriqueta Martinez, Gustavo Jarchum, Gabriela Celia Perinotto, Teresa Barraza, Sergio Ciarlo, Christine Rojas, Rosa Oliday Rios Jiménez, Carmino De Souza, Martina Manni, Eliana C M CM Miranda, Massimo Federico, Bryan Valcarcel, Carlos Chiattone, Luis Enrique Malpica Castillo

Blood (2023) 142 (Supplement 1): 186.

https://doi.org/10.1182/blood-2023-187254

Published: 2023

Journal Articles

Outcomes of Newly Diagnosed Hodgkin Lymphoma Patients in 4 Academic Centers in Paraguay. the Impact to Access to PET-CT Scanning in Survival

Seisha Alana Von Glasenapp, Maria Elvira Enciso Arrua, Alfredo Quiroz, Aline Nicole Paats, Laura Morel, Leticia Rocio Jiménez, Lidiane Andino, Victor Ladislao Salinas, Bryan Valcarcel, Luis Enrique Malpica Castillo

Blood (2023) 142 (Supplement 1): 6217.

https://doi.org/10.1182/blood-2023-186387

Published: 2023

Journal Articles

Treatment Patterns and Survival of Patients with Relapsed and Refractory Classical Hodgkin Lymphoma in Latin America

Seisha Alana Von Glasenapp Gossen, Humberto Martinez-Cordero, Luis Villela, Perla Rocio Colunga-Pedraza, Fernando Perez-Jacobo, Arianna Robles, Diego Fernando Garces PAZ, Henry Idrobo, Denisse Castro, Sally Rose Paredes, Brady E Beltran, Ana Carolina Oliver, Victoria Irigoin, Juan Alejandro Ospina, Rosa Oliday Rios

Blood (2022) 140 (Supplement 1): 9429–9430.

https://doi.org/10.1182/blood-2022-171102

Published: 2022

Journal Articles

Evolution of Treatment Patterns and Prognostic Biomarkers in Latin American Patients with Chronic Lymphocytic Leukemia: A Study By the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2022) 140 (Supplement 1): 10918–10920.

https://doi.org/10.1182/blood-2022-168276

Published: 2022

Journal Articles

Validating the Prognostic Value of Anemia and Thrombocytopenia in Latin American Patients with Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2022) 140 (Supplement 1): 6708–6710.

https://doi.org/10.1182/blood-2022-168165

Published: 2022

Journal Articles

Serum Albumin and Neutrophil-to-Lymphocyte Ratio, Two Independent Factor Predicting Survival in Patients with Follicular Lymphoma: A Multi-Institutional Retrospective Cohort of 741 FL, from the Latin American Lymphoproliferative Study Group (GELL)

Blood (2021) 138 (Supplement 1): 4515.

https://doi.org/10.1182/blood-2021-149662

Published: 2021

Journal Articles

Updated Analysis Confirms Sustained Poor Prognosis of COVID-19 in Patients with Lymphoma in Latin America: A Cohort of 160 Patients from Gell

Blood (2021) 138 (Supplement 1): 2520.

https://doi.org/10.1182/blood-2021-153875

Published: 2021

Journal Articles

Biological and Classical Prognostic Factors with Impact on Overall Survival in Patients with Early Stage (I/II) Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2021) 138 (Supplement 1): 2516.

https://doi.org/10.1182/blood-2021-152724

Published: 2021

Journal Articles

Proposal of a Novel Latin American International Prognostic Index (LATAM-IPI) for Diffuse Large B-Cell Lymphoma (DLBCL) By the Grupo Para El Estudio De Linfoproliferativos En Latino-America (GELL)

Luis Villela Villela, MDMC, Ana Ramirez-Ibarguen, MD, Brady E Beltran, MD, Camila Peña, MD, Denisse A. Castro, MD, Gladys P Agreda-Vasquez, MD, Myrna Candelaria, MDPharmD, Maria Alejandra Torres Viera, MD, Henry Idrobo, MD, Lorena Fiad, MD, Fabiola Valvert, MD, Efreen Montaño Figueroa, MD PhD, Juan Ospina Idarraga, Alana Von Glasenapp, MD, Sally Paredes, MD, Melani Otañez, MD, Fernando Perez-Jacobo, Daniela Zambrano, Humberto Martínez Cordero, MD, Virginia Otero, MD, Lidiane Andino, Mercedes Royg Arriola, MD, Maria Elvira Enciso, MD, Maria Prates, MD, Cristaldo Nancy, MD, Ivan Perdomo, MD, Maria E Cabrera, MD, María Lorena Cardozo, MD, Cristobal Augusto Frutos Ortiz, MD, Eloisa Riva, MD, Juan Antonio Choque, MD, Alfredo Reinaldo Quiroz, MD, Guilherme Fleury Perini, MD, David Gomez-Almaguer, MD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, Marcos Distefano, Katerine Garcia, Carolina Feres, MD, Mariana Kalmus, Julian Cordova, Magali DelosRios, MD, Rosio Baena, MD, Luis Malpica Castillo, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD

Blood (2020) 136 (Supplement 1): 25–27.

https://doi.org/10.1182/blood-2020-142836

Published: 2020

Journal Articles

Follicular Lymphoma in Latin America: Real-World Experience from 763 Patients

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-141943

Published: 2020

Journal Articles

COVID-19 in Patients with Lymphoma: A Grupo De Estudio Latinoamericano En Linfoproliferativos (GELL) Retrospective Study

Guilherme Fleury Perini, MD, Juan Alejandro Ospina Idarraga, Maria Alejandra Torres Viera, MD, Brady E Beltran, MD, Denisse A. Castro, MD, Victoria Otero, MD, Mariana Kalmus, Lorena Fiad, MD, Camila Peña, MD, Henry Idrobo, MD, Myrna Candelaria, MDPharmD, Alana Von Glasenapp, MD, Ivan Perdomo, MD, Carolina Feres, MD, Maria Prates, MD, Sally Rose Paredes, MD, Fernando Pérez-Jacobo, MD, Ana Ramirez-Ibarguen, MD, Claudia Gajardo, MD, Macarena Alejandra Roa Salinas, Humberto Martínez Cordero, MD, Melani Otañez, MD, Fabiola Valvert, MD, Efreen Montaño Figueroa, MD PhD, Marcos Di Stefano, MD, Rosio Baena, MD, Juan Antonio Choque, MD, Virginia Abello, MD, Ximena Valladares, MD, Sofia Sanchez, MD, Cristaldo Nancy, MD, Daniela Zambrano, Juan Felipe Lasso, MD, Andrea Noboa, MD, Christine Rojas, MD, Larissa LC Teixeira, Luis Malpica Castillo, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD, Luis Villela Villela, MDMC

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-142787

Published: 2020

Journal Articles

Impact of Cutaneous Involvement on the Clinical Outcome of Adult T-Cell Leukemia/Lymphoma: A Study from the Latin American Group of Lymphoproliferative Disorders (GELL)

Luis E Malpica Castillo, MD, Denisse A. Castro, MD, Camila Peña, MD, Henry Idrobo, MD, Daniel J Enriquez, MD, Lorena Fiad, MD, Maria Prates, MD, Victoria Otero, MD, Mirna Churin, MD, Milagros Altamirano, MD, Kelly Meza, MD, Celia Moises, MD, Roberto Oviedo-Pecho, MD, Antonio Paredes, MD, Gadwyn Sanchez, Laura Aguirre-Martinez, MS, Bryan Valcarcel, MD, Cristaldo Nancy, MD, Juan L. Maradei, MD, Luciana Guanchiale, MD, Pablo Soto, MD, Jose Luis Viñuela, MD, Maria Elena Cabrera, MD, Ursula Aviles-Perez, Gustavo Sandival-Ampuero, MD, Sally Rose Paredes, MD, Eloisa Riva, MD, Marcos Di Stefano, MD, Andrea Noboa, MD, Juan Antonio Choque, MD, Myrna Candelaria, MDPharmD, Alana Von Glasenapp, MD, Fabiola Valvert, MD, Marialejandra Torres Viera, MD, Guilherme Fleury Perini, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD, Juan Carlos Ramos, MD BS, Luis Villela Villela, MDMC, Brady Beltran, MD

Blood (2020) 136 (Supplement 1): 20–23.

https://doi.org/10.1182/blood-2020-140393

Published: 2020

Journal Articles

Sars Cov-2/COVID-19 in Multiple Myeloma Latin-American Patients COVID-Lamm Study on Behalf of Gelamm ( Grupo de Estudio Latino- Americano de Mieloma Múltiple )

Blood (2020) 136 (Supplement 1): 24–26.

https://doi.org/10.1182/blood-2020-142823

Published: 2020

Journal Articles

Epidemiology, Clinical Features, and Outcome of HTLV-1-Related Adult T-Cell Leukemia/Lymphoma in Latin America: A Study from the Latin American Group of Lymphoproliferative Disorders (GELL)

Blood (2020) 136 (Supplement 1): 18–21.

https://doi.org/10.1182/blood-2020-140630

Published: 2020

NARROW

Complete Response As a Determinant of Survival in Plasmablastic Lymphoma Plasmablat- GELL001 Study

Primary CNS Lymphoma in Latin America: A Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) Survey in 80 Cancer Centers in Latin America

Survival of Patients with Multiple Myeloma Treated with Bortezomib-Based Triplets and Autologous Hematopoietic Stem Cell Transplant As First Line in Latin America

Renal Failure in Patients with Newly Diagnosed Multiple Myeloma Eligible for Autologous Stem Cell Transplant in LATAM - on Behalf of Gelamm

Epidemiology, Clinical Features and Outcomes of Peripheral T-Cell Lymphoma in Latin America

Outcomes of Newly Diagnosed Hodgkin Lymphoma Patients in 4 Academic Centers in Paraguay. the Impact to Access to PET-CT Scanning in Survival

Treatment Patterns and Survival of Patients with Relapsed and Refractory Classical Hodgkin Lymphoma in Latin America

Evolution of Treatment Patterns and Prognostic Biomarkers in Latin American Patients with Chronic Lymphocytic Leukemia: A Study By the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Validating the Prognostic Value of Anemia and Thrombocytopenia in Latin American Patients with Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Serum Albumin and Neutrophil-to-Lymphocyte Ratio, Two Independent Factor Predicting Survival in Patients with Follicular Lymphoma: A Multi-Institutional Retrospective Cohort of 741 FL, from the Latin American Lymphoproliferative Study Group (GELL)

Updated Analysis Confirms Sustained Poor Prognosis of COVID-19 in Patients with Lymphoma in Latin America: A Cohort of 160 Patients from Gell

Biological and Classical Prognostic Factors with Impact on Overall Survival in Patients with Early Stage (I/II) Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Proposal of a Novel Latin American International Prognostic Index (LATAM-IPI) for Diffuse Large B-Cell Lymphoma (DLBCL) By the Grupo Para El Estudio De Linfoproliferativos En Latino-America (GELL)

Follicular Lymphoma in Latin America: Real-World Experience from 763 Patients

COVID-19 in Patients with Lymphoma: A Grupo De Estudio Latinoamericano En Linfoproliferativos (GELL) Retrospective Study

Impact of Cutaneous Involvement on the Clinical Outcome of Adult T-Cell Leukemia/Lymphoma: A Study from the Latin American Group of Lymphoproliferative Disorders (GELL)

Sars Cov-2/COVID-19 in Multiple Myeloma Latin-American Patients COVID-Lamm Study on Behalf of Gelamm ( Grupo de Estudio Latino- Americano de Mieloma Múltiple )

Epidemiology, Clinical Features, and Outcome of HTLV-1-Related Adult T-Cell Leukemia/Lymphoma in Latin America: A Study from the Latin American Group of Lymphoproliferative Disorders (GELL)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only